Federal Register / Vol. 86, No. 151 / Tuesday, August 10, 2021 / Notices 43669 

9. TEKTURNA (aliskiren hemifumarate) 

10. VIMOVO (naproxen/esomeprazole 

magnesium) 

11. VIREAD (tenofovir disoproxil 

fumarate) 

12. XOFLUZA (baloxavir marboxil) 

Center for Devices and Radiological 

Health 

1. CONTEGRA PULMONARY VALVED 

CONDUIT (Humanitarian Device 

Exemption (HDE)) 

2. ELANA SURGICAL KIT (HDE) 

3. ENTERRA THERAPY SYSTEM (HDE) 

4. LIPOSORBER LA–15 SYSTEM (HDE) 

5. MEDTRONIC ACTIVA DYSTONIA 

THERAPY (HDE) 

6. MINIMALLY INVASIVE DEFORMITY 

CORRECTION (MID–C) SYSTEM 

7. PLEXIMMUNE IN–VITRO 

DIAGNOSTIC TEST (HDE) 

8. PULSERIDER ANEURYSM NECK 

RECONSTRUCTION DEVICE (HDE) 

9. THE TETHER—VERTEBRAL BODY 

TETHERING SYSTEM 

Dated: August 5, 2021. 

Lauren K. Roth, 

Acting Principal Associate Commissioner for 

Policy. 

[FR Doc. 2021–17041 Filed 8–9–21; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Notice is hereby given of a meeting of 

the HEAL (Helping to End Addiction 

Long-Term) Multi-Disciplinary Working 

Group. 

The meeting will be open to the 

public as indicated below via NIH 

Videocast. Individuals who need special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The program documents 

and the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the program 

documents, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: HEAL MultiDisciplinary Working Group (MDWG) 

Meeting. 

Date: September 1–2, 2021. 

Open: September 01, 2021, 10:30 a.m. to 

11:30 a.m. 

Closed: September 02, 2021, 11:30 a.m. to 

4:30 p.m. 

Closed: September 02, 2021, 10:30 a.m. to 

3:45 p.m. 

Agenda: Provide an update on Helping to 

End Addiction Long-Term (HEAL) Initiative 

projects and obtain expertise from MDWG 

relevant to the NIH HEAL Initiative and to 

specific HEAL projects. 

Videocast: The open portion of the meeting 

will be live webcast at: https://

videocast.nih.gov/. 

Place: National Institutes of Health, 

Building 1, Wilson Hall, 1 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Rebecca G Baker, Ph.D., 

Office of the Director, National Institutes of 

Health, 1 Center Drive, Room 103A, 

Bethesda, MD 20892, (301) 402–1994, 

Rebecca.baker@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the Office 

of the Director for the NIH HEAL Initiative 

website: https://heal.nih.gov/news where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: August 5, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17012 Filed 8–9–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Center for Scientific 

Review Advisory Council. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

URL for virtual access:—https://

videocast.nih.gov/watch=42556 

Name of Committee: Center for Scientific 

Review Advisory Council. 

Date: September 27, 2021. 

Time: 1:00 p.m. to 4:30 p.m. 

Agenda: Provide advice to the Director, 

Center for Scientific Review (CSR), on 

matters related to planning, execution, 

conduct, support, review, evaluation, and 

receipt and referral of grant applications at 

CSR. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Bruce Reed, Ph.D., Deputy 

Director, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, (301) 594–9159, 

reedbr@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: https://

public.csr.nih.gov/AboutCSR/Organization/ 

CSRAdvisoryCouncil, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 5, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17043 Filed 8–9–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Listing of Members of the 

National Institutes of Health’s Senior 

Executive Service 2021 Performance 

Review Board (PRB) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Institutes of 

Health (NIH) announces the persons 

who will serve on the National 

Institutes of Health’s Senior Executive 

Service 2021 Performance Review 

Board. 

FOR FURTHER INFORMATION CONTACT: For 

further information about the NIH 

Performance Review Board, contact Mr. 

Kha Nguyen, Director, Division of 

Senior and Scientific Executive 

Management, Office of Human 

Resources, National Institutes of Health, 

Building 31, Room 1C31P, Bethesda, 

Maryland 20892, telephone 

301.594.3022 (not a toll-free number), 

email kha.nguyen@nih.gov. 

SUPPLEMENTARY INFORMATION: This 

action is being taken in accordance with 


jbell on DSKJLSW7X2PROD with NOTICES